Oliver Curme

Retired venture capitalist and angel investor with a focus on technology and a track record of investing in Israeli startups.

Angel Investor Active Chestnut Hill, United States
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$4.5M
total disclosed, rounds participated
Stages

About

Oliver Curme is a retired venture capitalist who spent two decades at Battery Ventures, focusing on computer and software investments. After his retirement from Battery Ventures in 2005, he invested in China and served as chairman of a clean-tech venture capital fund. Since 2014, he has been involved in education at the Harvard Institute for Learning in Retirement and the Brandeis Osher Lifelong Learning Institute. Curme has also made personal investments, including in the Israeli cancer treatment developer Efranat. He resides in Chestnut Hill and Lenox, Massachusetts.

Portfolio · 1

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Oliver Curme's primary investment focus by sector?
Oliver Curme has concentrated investments in the Health Tech & Life Sciences sector, with one recorded investment in this area.
Can you name a notable company in Oliver Curme's portfolio?
A notable company in Oliver Curme's portfolio is Efranat Pharma, which focuses on anticancer immunotherapy treatment.
What is the most recent investment activity recorded for Oliver Curme?
Oliver Curme's most recent recorded investment activity was in November 2014, with one investment round completed that month.
What funding stage does Oliver Curme typically invest in?
Oliver Curme has made one recorded investment at the Seed funding stage.
What was the funding amount for Efranat Pharma?
Efranat Pharma raised $4.5M in a round where Oliver Curme participated.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Radar intelligence

Patents

EPO1